I don't have time to follow CKD script advice
I was interested in the letter from Dr Donal O'Donoghue (3 October) on prescribing safety in kidney patients.
I wonder whether, as national clinical director for kidney care, he could direct me to a dependable source of information on which drugs need dose modification in renal impairment, haemodialysis and peritoneal dialysis.
Both I and our local pharmaceutical adviser have searched in vain: even the haemodialysis unit and local nephrology department were unable to help.
Each drug may be specified in the BNF – but I'm afraid I don't have time to check every drug in every patient with CKD3 or above.
From Dr Mary Hawking, Dunstable, Bedfordshire